GENZYME CORP 3 SEC Filings

Filed On	Filing
06 Apr 2011	Form 3: Sanofi-aventis, 10% owner and 1 other Holds 184,038,545 shares of Common Stock, $0.01 par value
18 Jun 2010	Form 3: Fenton Dennis M, Director Holds 355 shares of Genzyme common stock (GENZ)
18 Jun 2010	Form 3: Ende Eric J, Director No securities owned
18 Jun 2010	Form 3: Burakoff Steven, Director No securities owned
16 Apr 2010	Form 3: Whitworth Ralph V, Director Holds 10,622,708 shares of Genzyme common stock (GENZ)
09 Mar 2010	Form 3: Canute Scott A, Executive VP No securities owned
10 Dec 2009	Form 3: Bertolini Robert J, Director No securities owned
10 Dec 2008	Form 3: Amello Jason, CorpContrllr,ChiefAccntOfficer Holds 1,428 shares of Genzyme common stock (GENZ)
23 May 2008	Form 3: Meeker David P, President LSD Therapeutics Holds 1,886 shares of Genzyme common stock (GENZ)
23 May 2008	Form 3: Geraghty James A, Senior Vice President Holds 2,025 shares of Genzyme common stock (GENZ)
23 May 2008	Form 3: DesRosier Thomas, Sr VP General Counsel Holds 716 shares of Genzyme common stock (GENZ)
23 May 2008	Form 3: Bamforth Mark R, Sr.VP, Corp. Operations & Phar Holds 158 shares of Genzyme common stock (GENZ)
08 Jun 2007	Form 3: Genzyme Corp, 10% owner and 1 other · BIOENVISION INC
23 Feb 2007	Form 3: Genzyme Corp, 10% owner · DYAX CORP Holds 4,969,820 shares of Common Stock
10 Mar 2006	Form 3: Syron Richard F/CA, Director Holds 11 shares of Genzyme common stock (GENZ)
06 Jun 2005	Form 3: Smith Sandford D, Senior Vice President Holds 3,229 shares of Genzyme common stock (GENZ)
27 May 2004	Form 3: Boudreaux Gail, Director Holds 0 shares of Genzyme General common stock (GENZ)
12 Sep 2003	Form 3: Genzyme Corp, 10% owner and 1 other Holds 23,613,646 shares of SangStat Medical Corporation common stock (SANG)
27 Aug 2003	Form 3: Gemayel Georges, Executive Vice President

Comments